Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Stock and American Depositary Receipts
-
Shares outstanding
-
1,226,467,754
-
Total 13F shares
-
251,169,166
-
Share change
-
+6,906,630
-
Total reported value
-
$12,889,539,401
-
Put/Call ratio
-
18%
-
Price per share
-
$51.34
-
Number of holders
-
601
-
Value change
-
+$356,108,026
-
Number of buys
-
292
-
Number of sells
-
223
Institutional Holders of Sanofi - Common Stock and American Depositary Receipts (SNY) as of Q1 2022
As of 31 Mar 2022,
Sanofi - Common Stock and American Depositary Receipts (SNY) was held by
601 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
251,169,166 shares.
The largest 10 holders included
Dodge & Cox, FMR LLC, Fisher Asset Management, LLC, BlackRock Inc., BANK OF AMERICA CORP /DE/, Boston Partners, PRICE T ROWE ASSOCIATES INC /MD/, Invesco Ltd., HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC, and Camber Capital Management LP.
This page lists
608
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.